РОЛЬ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ЭПИТЕЛИАЛЬНОГО РАКА ЯИЧНИКОВ
https://doi.org/10.18027/2224-5057-2012-2-14-20
Аннотация
Хирургический подход используется у больных эпителиальным раком яичников с целью диагностики и стадирования, радикального и паллиативного лечения. Эта статья посвящена роли хирургии в профилактике, диагностике, стадировании и лечении ранних и распространенных форм заболевания. В статье также кратко освящено паллиативное хирургическое лечение.
Об авторе
H. Narendra
Department of surgical oncology, Kasturba Medical College, Manipal University
Индия
Department of surgical oncology, Kasturba Medical College, Manipal University, Manipal, India 576104
Индия
Department of surgical oncology, Kasturba Medical College, Manipal University, Manipal, India 576104
Список литературы
1. Chaudhry K. Epidemiology of Cancer of Ovary: Changing Trends. Indian journal of medical & paediatric oncology. 30:suppl 1.2009.8.
2. Permuth-Wey J., Sellers T.A.. Epidemiology of ovarian cancer. Methods in Molecular Biology, 2009;472:413–437.
3. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109:221-227.
4. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327–40.
5. Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006 ;296:185-92.
6. Aletti GD, Gallenberg MM,Cliby WA, Jatoi A, Hartmann LC. Current Management Strategies for Ovarian Cancer. Mayo Clin Proc. 2007;82:751-770.
7. Kauff ND, Barakat RR. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol. 2007 ;25:2921-7.
8. Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072-6.
9. Meier WJ. Lymphadenectomy in stage I ovarian cancer. Proc Am Soc Clin Oncol 2000;19:1541.
10. Benedetti-Panici P, Greggi S, Maneschi F, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993;51:150-4.
11. Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62.
12. Baiocchi G, Raspagliesi F, Grosso G, et al. Early ovarian cancer: Is there a role for systematic pelvis and paraortic lymphadenectomy? Int J Gynecol Cancer 1998;8:103-108.
13. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. J Clin Oncol. 2007;25:1-16.
14. Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007;96:1817-22.
15. Maggioni A, Panici PB, Dell›Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699-704.
16. Vergote I. Role of surgery in ovarian cancer: an update. Acta Chir Beig. 2004;104:246-56.
17. Earle CC, Schrag D, Neville BA, et al. Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients. J Natl Cancer Inst 2006;98:172 – 80.
18. Engelen MJA., Kos HE, Willemse PHB, et al. Surgery by Consultant Gynecologic Oncologists Improves Survival in Patients with Ovarian Carcinoma. Cancer 2006;106:589–98.
19. Martinek IE, Kehoe S. When Should Surgical Cytoreduction in Advanced Ovarian Cancer Take Place? J Oncol. 2010:85;20-28.
20. Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer. Minerva Ginecol. 2006;58:393-403.
21. Horng HC, Yuan CC, Lai CR, Wang PH. Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery. Eur J Gynaecol Oncol. 2007;28:43-4.
22. Bae J, Lim MC, Choi JH, et al. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol On col.2009;20:101-106.
23. Park JY, Kim DY, Suh DS, et al. Outcomes of fertilitysparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol. 2008;110:345-53.
24. Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2009;19:1199-204.
25. Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res. 2008;178:79-95.
26. Kwon YS, Hahn SH, Kim TJ, et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol. 2009; 20:44-47.
27. Canis M, Jardon K, Niro J, et al. [Endoscopic management of gynecological malignancies: an update. 2007. Bull Acad Natl Med. 2007;191:1357-65.
28. Jung US, Lee JH, Kyung MS, Choi JS. Feasibility and efficacy of laparoscopic management of ovarian cancer. J. Obstet. Gynaecol. Res 2009;35:113–118.
29. Park JY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer. 2008;18:1202-9.
30. Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol. 2008;15:2012-9.
31. Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer? J Minim Invasive Gynecol. 2009; 16:250-62.
Рецензия
Для цитирования:
Narendra H. РОЛЬ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ЭПИТЕЛИАЛЬНОГО РАКА ЯИЧНИКОВ. Злокачественные опухоли. 2012;1(2):14-20. https://doi.org/10.18027/2224-5057-2012-2-14-20
Просмотров: 5481
Послать статью по эл. почте 